Beyond cost: a value-based framework for biosimilar procurement in emerging markets - the Thai experience. [PDF]
Assawamakin A+3 more
europepmc +1 more source
Biosimilars in der Schweiz : Medizin gegen die steigenden Gesundheitskosten? [PDF]
Kobler, Irene+5 more
core +1 more source
Innovative Formulation Strategies for Biosimilars: Trends Focused on Buffer-Free Systems, Safety, Regulatory Alignment, and Intellectual Property Challenges. [PDF]
Bas TG.
europepmc +1 more source
Sandoz Inc. v. Amgen Inc.: Removing Barriers to Market Access for Biosimilar Manufacturers [PDF]
Koya, Moyosore O.
core +1 more source
Pharmacovigilance of biosimilars: challenges and possible solutions [PDF]
Thijs J. Giezen
openalex +1 more source
Real-World Evidence Assessing the Safety of Administering Intravenous Rituximab Biosimilar in the First Cycle and Subcutaneous Rituximab in Subsequent Cycles in B-Cell Lymphoma Patients. [PDF]
Almandeel T+8 more
europepmc +1 more source
Saving money in the European healthcare systems with biosimilars [PDF]
Robert Haustein
openalex +1 more source
Perceptions and Preferences for Defining Biosimilar Products in Prescription Drug Promotion. [PDF]
Johnson M+4 more
europepmc +1 more source